Baiyunshan (600332.SH) Subsidiary Plans to Invest HKD 350 Million in Asia Healthcare Fund

date
16/11/2026
Zhitong Finance APP News, Baiyunshan (600332.SH) issued an announcement that its wholly-owned subsidiary Guangzhou Pharmaceutical Baiyunshan Hong Kong Co., Ltd. plans to contribute HK$350 million to subscribe for a limited partnership interest in Walgreens Boots Alliance Capital Greater Health Limited Partnership Fund (the "Asia Greater Health Fund"), accounting for 35% of the fund upon completion of fundraising. The fund focuses on investing in the healthcare industry (including but not limited to the healthcare, life sciences and consumer goods industries), covering early-stage, growth-stage and other portfolio investments. Through this investment, the company can implement its internationalization strategy more efficiently: first, efficiently access overseas networks and enhance its ability to obtain information on high-quality projects and cutting-edge technologies; second, fund cooperation can enable the company to conduct overseas investment layout more flexibly.